Point72 Europe (London) LLP Liva Nova PLC Transaction History

Point72 Europe (London) LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.76 - $64.15 $6.06 Million - $7.51 Million	117,100 New	117,100 $6.42 Million
Q3 2023 Nov 14, 2023	BUY	$50.12 - $58.87 $2.79 Million - $3.27 Million	55,600 New	55,600 $2.94 Million
Q3 2018 Nov 14, 2018	SELL	$101.02 - $130.95 $7.26 Million - $9.41 Million	-71,872 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $2.98 Million - $3.85 Million	36,500 Added 103.19%	71,872 $7.17 Million
Q1 2018 May 15, 2018	BUY	$79.95 - $89.74 $2.83 Million - $3.17 Million	35,372 New	35,372 $3.13 Million

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.57B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.